It has been confirmed that serum IL‐33 was involved in various diseases including asthma, obesity, atherosclerosis, and Alzheimer disease (Fu et al., 2016; Lloyd, 2010; Miller et al., 2008, 2010). This evidence concerns the gene IL33 and early-onset autosomal dominant Alzheimer disease.